Comparison of complications and oncology outcomes of immunotherapy alone and combination in metastatic castration-resistant prostate cancer (mCRPC): a systematic review and meta-analysis.

Int J Surg · 2026 · PMC12825570 · PMID 40865972

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In addition, studies of radiotherapy combined with sipuleucel-T also showed that the median progression-free survival (PFS) in the combined treatment group tended to prolong, although the difference did not reach statistical significance [ 19 ] .

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.